Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

Joo Hyun OhHye Won LeeDong Hyun SinnJun Yong ParkBeom Kyung KimSeung Up KimDo Young KimSang Hoon AhnWonseok KangGeum-Youn GwakMoon Seok ChoiJoon Hyeok LeeKwang Cheol KohSeung Woon PaikYong-Han Paik

Published in: Hepatology international (2021)

Among CHB patients under antiviral therapy showing suppressed HBV replication, low CAP value predicted higher risk for HCC among ACLD patients, indicating that CAP value has a prognostic implication in this population.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
prognostic factors
patient reported outcomes
mesenchymal stem cells
bone marrow
smoking cessation